Approved Study Database

Ref. No. Scientific Title Principal investigator
2010.427 The Second INTEnsive blood pressure Reduction in Acute Cerebral haemorrhage Trial An international randomised controlled trial to establish the effects of early intensive blood pressure lowering in patients with intracerebral haemorrhage Prof. WONG Lawrence K.S.
2010.422 A Phase II trial of BAY 86-9766 plus sorafenib as a first line systemic treatment for hepatocellular carcinoma (HCC) Prof. Yeo Winnie
2010.415 Randomized double-blind investigation of glycopyrrolate as an adjunct to phenylephrine for maintenance of maternal blood pressure during spinal anaesthesia for Caesarean section Prof Ngan Kee Warwick
2010.404 Electroacupuncture Analgesia for Colonoscopy: A Prospective, Randomized, Double-Blind, Sham-Controlled Study Professor NG Simon Siu-man
2010.400 Clinical Bioequivalence Study on Two Frusemide Formulations Professor Lee Hon-leung, Vincent
2010.399 Phase I, open label, randomized study to examine the pharmacokinetics, safety and tolerability of different oral doses of TMC435 after single and repeated dosing in healthy Chinese subjects Prof. Tomlinson Brian
2010.392 A prospective randomized double-blinded placebo controlled study on the effects of adjuvant tamsulosin OCAS in the treatment outcome of patient receiving extracorporeal shock wave lithotripsy for renal calculi Prof Ng Chi Fai
2010.390 Randomized controlled trial of S-1 versus docetaxel in patients with non-small cell lung cancer who have received a platinum-based treatment Prof. MOK Tony Shu Kam
2010.388 Nurse-initiated early pain management program for acute back pain in Emergency Medicine Ward Miss Yau Ching Ying
2010.385 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome Dr Yan Ping Yen Bryan
2010.383 A randomized, double blind, placebo controlled, parallel group trial for assessing the clinical benefit of Dronedarone 400mg BID on top of standard therapy in patients with permanent atrial fibrillation and additional risk factors Prof Wong Lawrence Ka Sing
2010.378 Complementary approaches to relieve post-stroke shoulder pain among stroke survivors in a nurse-led clinic Mr. Shum Edward
2010.372 The effectiveness of DASH dietary counselling in primary care on reduction of cardiovascular risks among Chinese subjects: a randomized controlled trial Professor WONG Chi Sang, Martin
2010.371 A Prospective Evaluation of the efficacy of Bipolar Transurethral Resection and Vaporization of Prostate for elderly/at risk patients with urinary retention Dr. Chan Chi Kwok
2010.366 Phase III Multi-Centre Open-Label Randomized Controlled Trial of Selective Internal Radiation Therapy (SIRT) versus Sorafenib in Locally Advanced Hepatocellular Carcinoma Prof. Yu Simon
2010.362 Effectiveness of fall alarm pad in fall prevention for the at risk group of the Chinese elderly in acute hospital of Hong Kong MR. SUNG Man Ho, Charles
2010.360 A Single-Dose, Open-Label, Phase 1 Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Oral Fampridine-PR 10 mg in Chinese, Japanese, and Caucasian Adult Healthy Volunteers Prof. Tomlinson Brian
2010.359 A Phase II Study of Transarterial Chemoembolization and Axitinib for the Treatment of Unresectable Hepatocellular Carcinoma Prof. CHAN Stephen Lam
2010.358 ABSORB EXTEND Clinical investigation: A continuation in the Clinical Evaluation of the ABSORB Bioresorbable Vascular Scaffold (BVS) System in the Treatment of Subjects with de novo Native Coronary Artery Lesions Prof. YU Cheuk Man
2010.356 A Multicenter, Randomized, Double-Blind, Phase 3 Study of Ramucirumab (IMC-1121B) Drug Product and Best Supportive Care (BSC) Versus Placebo and BSC as Second-Line Treatment in Patients With Hepatocellular Carcinoma Following First-Line Therapy With Sorafenib Dr. Chan Stephen Lam
2010.355 A Multi-Centre, international study to compare the use of Narrow Band Imaging (NBI) versus White light (WL) during TURB to assess recurrence of bladder cancer in terms of safety and efficacy Dr. CHAN Eddie Shu Yin
2010.354 A prospective randomised trial of bile duct cannulation using either 0.025" or 0.035" guidewire during endoscopic retrograde cholangio-pancreatoscopy (WGC study) Prof. Lau James Yun Wong
2010.348 A phase III, randomized, double-blind, placebo-controlled, parallel group, efficacy and safety study of BI 10773 (10 mg and 25 mg administered once daily) as add on to pre-existing antidiabetic therapy over 52 weeks in patients with type 2 diabetes mellitus and renal impairment and insufficient glycaemic control Dr. Cheng Yuk Lun
2010.347 A 24-week, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of vildagliptin 50mg bid as an add-on therapy to insulin, with or without metformin, in patients with type 2 diabetes mellitus Dr. Ozaki Risa
2010.346 TRK-100STP Phase IIb/III Clinical Study Protocol – Chronic Renal Failure (Primary Glomerular Disease / Nephrosclerosis) Dr. CHENG Yuk Lun
2010.345 A phase III, randomised, double-blind, placebo-controlled, parallel group, efficacy and safety study of BI 10773 (10 mg and 25 mg administered once daily) as add on to pre-existing antidiabetic therapy over 52 weeks in patients with type 2 diabetes mellitus and renal impairment and insufficient glycaemic control Dr. Ozaki Risa
2010.344 A phase III randomised, double-blind, active-controlled parallel group efficacy and safety study of BI 10773 compared to glimepiride administered orally during 104 weeks with a 104-week extension period in patients with type 2 diabetes mellitus and insufficient glycaemic control despite metformin treatment Dr. OZAKI Risa
2010.338 The effect of Transcutaneous Electrical Nerve Stimulation (TENS) on pain relief, anxiety alleviation, satisfaction of pain relief and sense of control in early labor in Hong Kong Miss Yu Chi Mei
2010.336 A Phase 2, Double-Blind, Randomized, Placebo-Controlled Study of FG-3019 in Subjects with Liver Fibrosis due to Chronic Hepatitis B Infection Prof. CHAN Henry Lik Yuen
2010.333 A randomized comparison between white light endoscopy (WLE) and bright narrow band imaging (B-NBI) in the diagnosis of colonic adenomas in asymptomatic subjects undergoing screening colonoscopy (B-NBI study) Prof. Lau James Yun Wong
2010.332 For CUHK medical year-one students, is cardiopulmonary resuscitation (CPR) video self-instruction training effective in improving in their skill when compared with traditional classroom training? Miss Lam Chui Wing
2010.331 A randomized controlled study to examine the effect of lifestyle modification program in obstructive sleep apnea patients Prof. Hui David Shu Cheong
2010.322 Pharmacogenomics of nicotinic acid with laropiprant in Hong Kong Chinese patients with dyslipidemia Prof Tomlinson Brian
2010.317 Clinical bioequivalence study on two propafenone formulations Professor Lee Hon-leung, Vincent
2010.298 A randomized, double-blind, parallel group study of the safety and effect on clinical outcome of tocilizumab SC versus tocilizumab IV, in combination with traditional disease modifying anti-rheumatoid arthritis drugs (DMARDs), in patients with moderate to severe active rheumatoid arthritis Prof. Tam Lai Shan
2010.272 The Asia-Pacific Flexible Dose Study of Dapoxetine and Patient Satisfaction in Premature Ejaculation Therapy Dr Mak Siu King
2010.271 Efficacy and safety of lixisenatide in patients with type 2 diabetes mellitus insufficiently controlled by metformin (with or without sulfonylurea): a multicenter, randomized, double-blind, parallel-group, placebo-controlled study with 24-week treatment period Dr Chow Chun Chung Francis
2010.270 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Cardiovascular Outcomes Following Treatment with Alogliptin in Addition to Standard of Care in Subjects with Type 2 Diabetes and Acute Coronary Syndrome Dr Chow Chun Chung, Francis
2010.267 A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety and immunogenicity of GSK Biologicals’ gE/AS01B vaccine when administered intramuscularly on a 0, 2-month schedule in adults aged 70 years and older Prof. HUI David Shu Cheong
2010.266 A phase III, randomized, observer-blind, placebo-controlled, multicentre, clinical vaccination trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals’ gE/AS01B vaccine when administered intramuscularly on a 0, 2-month schedule in adults aged 50 years and older Prof. HUI David Shu Cheong
2010.265 A double-blind, parallel group placebo-controlled study of Prazosin for recurrent nightmares in patients with major depressive disorder Prof. Wing Yun Kwok
2010.260 Clinical bioequivalence study on two amisulpride formulations Professor Lee Hon-leung, Vincent
2010.253 Phase 2 Study of Axitinib in Patients with Recurrent or Metastatic Nasopharyngeal Carcinoma Prof. CHAN Anthony
2010.252 A study to evaluate the efficacy of comprehensive nutritional program to head & neck cancer patients undergoing radical radiation therapy Ms Yuen Mei Lin
2010.251 Uncontrolled, open-label, non-randomized, phase 1 study to investigate the pharmacokinetics, safety, tolerability, and efficacy of BAY 73-4506 in Chinese patients with advanced, refractory solid tumors Associate Professor Ma Brigette Buig-Yue
2010.247 Phase III Protocol Comparing a Microfracture Treatment to a Cartipatch_ Chondrocyte Graft Treatment in Femoral Condyle Lesions Professor Chan Kai Ming
2010.239 Randomized placebo controlled trial of vitamin B12 supplementation to prevent cognitive decline in older diabetic outpatients with mild vitamin B12 deficiency Prof. KWOK Timothy
2010.227 The Observational Registry Collecting Data On Gastroenteropancreatic Neuroendocrine Tumor Patients (GEP-NET Registry) Dr. MA Ronald Ching Wan
2010.224 Food labeling and self management in primary care patients with hypertension Professor Chor Sin Yee, Josette
2010.223 Dysphagia rehabilitation for nasopharyngeal carcinoma patients post radiotherapy: a randomised-controlled trial Prof. TONG Michael Chi Fai

Page 260 of 287.